Effect of dual antiplatelet therapy prolongation in acute coronary syndrome patients with both high ischemic and bleeding risk: insight from the OPT-CAD study

Effect of dual antiplatelet therapy prolongation in acute coronary syndrome patients with both high ischemic and bleeding risk: insight from the OPT-CAD study

BackgroundIn current clinical practice, controversy remains regarding the clinical benefits of prolonged dual antiplatelet therapy (DAPT) in acute coronary syndrome (ACS) patients facing high risks of both ischemia and bleeding (“bi-risk”) following percutaneous coronary intervention (PCI). This stu...

Full description

Bibliographic Details
Main Authors: Kun Na, Miaohan Qiu, Ningxin Wei, Jiayin Li, Chenghui Yan, Jing Li, Yi Li, Yaling Han
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
acute coronary syndrome
dual antiplatelet therapy
ischemic complications
bleeding complications
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1201091/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1201091/full

Similar Items